Not applicableStudy completedNCT04239248What this trial is testing"Tasty&Healthy" Dietary Approach for Crohn's DiseaseWho this might be right forCrohn Disease Shaare Zedek Medical Center 129
Post-approval studies (Phase 4)Not Yet RecruitingNCT07059130What this trial is testingEvaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Moderate to Severe Crohn's Disease and Ulcerative ColitisWho this might be right forCrohn Disease (CD)Crohns DiseaseUlcerative Colitis (UC) Rubix LS 150
Large-scale testing (Phase 3)Study completedNCT00206674What this trial is testingEfficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn Disease Genzyme, a Sanofi Company 286
Testing effectiveness (Phase 2)Study completedNCT00055536What this trial is testingSafety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's DiseaseWho this might be right forCrohn's Disease Biogen 60
Large-scale testing (Phase 3)Study completedNCT02499783What this trial is testingStudy to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's Disease AbbVie 205
Large-scale testing (Phase 3)Study completedNCT00783692What this trial is testingStudy of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's Disease Millennium Pharmaceuticals, Inc. 1,116
Large-scale testing (Phase 3)Study completedNCT00543374What this trial is testingExtended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's DiseaseWho this might be right forCrohn's Disease Mesoblast, Inc. 98
Large-scale testing (Phase 3)Study completedNCT00552058What this trial is testingStudy to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's DiseaseWho this might be right forCrohn Disease UCB Pharma 439
Large-scale testing (Phase 3)Study completedNCT00077779What this trial is testingAdalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's DiseaseWho this might be right forCrohn's Disease Abbott 854
Early research (Phase 1)Study completedNCT00868660What this trial is testingHealthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending DoseWho this might be right forInflammatory Bowel Disease Zealand Pharma 66
Early research (Phase 1)Ended earlyNCT05542355What this trial is testingEXL01 in the Maintenance of Steroid-induced Clinical Response/Remission in Participants With Mild to Moderate Crohn's DiseaseWho this might be right forCrohn Disease Exeliom Biosciences 8
Not applicableStudy completedNCT07600255What this trial is testingAssessment on the Deep Remission Rate and Its Influencing Factors of Individualized Ustekinumab Therapy in Patients With Crohn's DiseaseWho this might be right forCrohn's Diseases Second Affiliated Hospital of Wenzhou Medical University 156
Large-scale testing (Phase 3)Study completedNCT00152490What this trial is testingTest the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)Who this might be right forCrohn's Disease UCB Pharma 604
Large-scale testing (Phase 3)Study completedNCT00409617What this trial is testingStudy of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's DiseaseWho this might be right forCrohn's Disease Abbott 945
Large-scale testing (Phase 3)UnknownNCT00132184What this trial is testingVitamin D Treatment for Crohn´s DiseaseWho this might be right forCrohns Disease University of Aarhus 110
Large-scale testing (Phase 3)Study completedNCT00152425What this trial is testingStudy to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).Who this might be right forCrohn's Disease UCB Pharma 392
Testing effectiveness (Phase 2)Study completedNCT02501291What this trial is testingThalidomide in Treating Crohn's DiseaseWho this might be right forCrohn's Disease First Affiliated Hospital, Sun Yat-Sen University 47
Large-scale testing (Phase 3)Looking for participantsNCT07582458What this trial is testingModafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease MODIFI-IBD Trial)Who this might be right forInflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)Chronic Fatigue Radboud University Medical Center 60
Not applicableWithdrawnNCT04100005What this trial is testingA Pilot Study to Explore the Role of Gut Flora in Crohn's DiseaseWho this might be right forCrohn DiseaseCrohn ColitisCrohn's Ileocolitis+11 more ProgenaBiome
Large-scale testing (Phase 3)UnknownNCT02044952What this trial is testingEfficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction RemissionWho this might be right forInflammatory Bowel DiseasesCrohn's DiseaseGastrointestinal Diseases+2 more Zhu Weiming 40